Litcius/Paper detail

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, Amin H. Nassar, Elio Adib, Noha Abdel‐Wahab, Nikita Chintapally, Claire Drolen, Tatyana Feldman, Tarek Haykal, Caroline A. Nebhan, Swetha Kambhampati Thiruvengadam, Mingjia Li, Arjun Mittra, Michael Lorentsen, Chul Kim, Alexandra Drakaki, Michael A. Morse, Douglas B. Johnson, Ankit Mangla, Christopher Dittus, Praful Ravi, Robert A. Baiocchi, Elizabeth Y. Chiao, P Rubinstein, Sarvari V. Yellapragada, Ann S. LaCasce, Guru Sonpavde, Abdul Rafeh Naqash, Alex F. Herrera

2024Clinical Lymphoma Myeloma & Leukemia14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNivolumabInternal medicineBrentuximab vedotinCarboplatinOncologyDiscontinuationAdverse effectPembrolizumabLymphomaCancerChemotherapyImmunotherapyHodgkin lymphomaCisplatinViral-associated cancers and disordersLymphoma Diagnosis and TreatmentHIV Research and Treatment
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States | Litcius